Clinically Proven Safety Profile 1) Advantages: - Supported by clinical studies demonstrating low irritation (ideal for post-procedure skin)
BPC-157 provides researchers with a consistent tool for exploring peptide behavior in laboratory systems focused on structural and cellular dynamics
10.1093/jn/134.3.489 307 WuL
Researchers utilise copper peptide GHK-Cu in studies exploring peptide chemistry, extracellular matrix interactions, collagen biology, cellular communication, tissue regeneration pathways, and protein signalling
[2] Weiss JB, Phillips CJ, Malin EW, Gorantla VS, Harding JW, Salgar SK
In fertility and early embryonic development studies, male and female rats were administered twice weekly subcutaneous doses of 0.5, 1.5, or 3 mg/kg (0.3-, 1-, and 2-fold and 0.3-, 0.9-, and 2-fold, respectively, the MRHD of 15 mg once weekly based on AUC)